Wednesday news tips: Nov. 17, 2010
American Heart Association meeting report
2010-11-18
(Press-News.org) 9 a.m. Abstract 20649 – Some ICD recipients may not get optimal medical therapy
Guidelines recommending optimal medical therapy are not always followed for patients receiving implantable cardioverter-defibrillators (ICDs), a new study found.
Researchers examined optimal medical therapy — beta blocker and angiotensin converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) at discharge — among ICD patients with ejection fractions below 35 percent. Of the 231,725 patient stays analyzed, 73.1 percent of the patients received optimal medical therapy at discharge, 63.1 percent received ACEI, 16.6 percent received ARB and 87.8 percent received a beta blocker. Patients least likely to receive optimal medical therapy were those whose care was directed by a surgeon and those patients with a prior ICD. Race wasn't predictive.
"Despite guideline recommendations, more than one-quarter of ICD recipients are not medically optimized at the time of ICD implantation," researchers said. "These results highlight patient and provider characteristics that may be targets of quality improvement efforts to minimize gaps in heart failure care."
Amy Miller, M.D., Ph.D., Brigham & Women's Hospital, Boston, Mass.; (617) 525-6768; almiller@partners.org.
9:15 a.m. Abstract 15309 – Animal study finds promising anti-arrhythmic agent
The drug ghrelin reduced irregular heart rhythm by preventing the acute heart attack-induced loss of the protein phosphorylated connexin43 (Cx43) in rats, according to a new study.
Ghrelin is a group of hormones secreted primarily by stomach cells and has been implicated in the stimulation of fat storage and food intake.
Researchers exposed 52 rats to 30 minutes of ischemia, induced by blocking the left coronary artery. The rats were randomized into two groups: 26 received ghrelin and 26 got saline during 30 minutes of coronary artery ligation.
Ghrelin increased high-frequency (HF) power and decreased the low-frequency (LF)-to-HF ratio of heart rate variability. Rapid heartbeat occurred less often in rats receiving ghrelin compared to those on saline. Rats getting the drug showed only a slight loss of Cx43 in left ventricles while rats on saline had a marked reduction.
The findings suggest ghrelin could have potential as a new anti-arrhythmic medication, researchers said.
Takeshi Soeki, M.D., Ph.D., University of Tokushima, Tokushima, Japan; (011) 81886337851;
soeki@clin.med.tokushima-u.ac.jp.
9:30 a.m. Abstract 18482/P2022 – Mobile phone-based telemonitoring improves blood pressure control
A fully automated mobile phone-based telemonitoring system that actively engages patients in their care significantly improved blood pressure control among diabetics with uncontrolled systolic hypertension.
Patients received pre-programmed cell phones that automatically transmitted readings from a Bluetooth-enabled home blood pressure monitor.
Feedback is provided on the cell phone screen, instantaneously reporting the current blood pressure along with messages ranging from congratulations to a prompt to take additional readings over a certain period to get a reliable overall reading. If the blood pressure values are too high, patients are asked to make a follow-up appointment with their physician.
At 12 months, systolic blood pressure significantly dropped by 9.1 mm Hg in the telemonitoring group compared to a 1.6 mm Hg decrease in those monitoring their blood pressure at home in the standard manner.
Blood pressure control was achieved in 37 percent of the phone-based telemonitoring patients and only 14.2 percent of the controls.
If a three-day or two-week average exceeds a prespecified average, the doctor is notified. Physicians can review the results of their patients' blood pressure on a Web-based server.
The researchers are analyzing the possible reasons for the drop in blood pressure in patients using the telemonitoring system.
Alexander G. Logan, M.D., University of Toronto, Toronto; (416) 586-5187; logan@lunenfeld.ca.
11:45 a.m. Abstract 23153 – Large study finds no significant statins-cancer link
A large new investigation found no difference in cancer risk between statin and non-statin users for up to 10 years.
Statins are a class of cholesterol-lowering medications.
In the study, researchers paired older adult statin patients with non-statin users and followed them for up to 10 years. Researchers retrospectively analyzed more than 11 million patient records from a large database covering January 1990-February 2009.
Propensity scoring methods matched 45,857 comparison pairs of statin vs. non-statin patients. Before matching, cancer occurred in 23,906 of 203,763 (11.7 percent) statin users and in 17,457 of 159,004 (11.0 percent) non-statin users. After matching, cancer incidence in statin patients fell to 11.4 percent vs. 11.1 percent in non-statin users. Pairs were followed up for an average of eight years. Based on these results, no increased risk of cancer associated with statin use was found.
Paul Cload, Ph.D., GE HealthCare, Chalfont St Giles, Bucks, United Kingdom; paul.cload@ge.com.
INFORMATION:
Author disclosures are on the abstracts.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
NR10-1152 (SS10/Wednesday News Tips)
Additional resources:
Multimedia resources (animation, audio, video, and images) are available in our newsroom at Scientific Sessions 2010 - Multimedia. This will include audio interview clips with AHA experts offering perspective on news releases. Video clips with researchers will be added to this link after each embargo lifts.
Stay up to date on the latest news from American Heart Association scientific meetings, including Scientific Sessions 2010, by following us at www.twitter.com/heartnews. We will be tweeting from the conference using hashtag #AHA10News.
ELSE PRESS RELEASES FROM THIS DATE:
2010-11-18
Cardiac stem cells — even in elderly and sick patients — could generate new heart muscle and vessel tissue and be used to treat heart failure, according to research presented at the American Heart Association's Scientific Sessions 2010.
Scientists surgically removed tissue from the muscular wall of the heart's chambers in 21 patients. They then isolated and multiplied the cardiac stem cells (CSCs) found there. Most of the patients had ischemic cardiomyopathy (enlarged and weakened muscle due to coronary artery disease). Eleven also had diabetes. The average age of patients ...
2010-11-18
San Diego -- Researchers from Georgetown University Medical Center's departments of neuroscience, pharmacology, physiology, biochemistry, molecular and cellular biology, and the interdisciplinary program of neuroscience will present more than 50 research abstracts at the 40th Annual Meeting of the Society for Neuroscience Nov. 13th through the 17th in San Diego.
Modulation of temporal relationships between default mode and task-positive networks by the dopamine transporter genotype during working memory and the resting state
Session: Imaging Human Memory Function
Abstract/Poster: ...
2010-11-18
Two separate discoveries by researchers at the University of Wisconsin-Milwaukee (UWM) offer potential for development of a first-ever pharmacological treatment for cocaine addiction.
In one study, a common beta blocker, propranolol, currently used to treat hypertension and anxiety, has shown to be effective in preventing the brain from retrieving memories associated with cocaine use in animal-addiction models, according to Devin Mueller, UWM assistant professor of psychology and a co-author with James Otis of the research.
The work was presented today at the annual ...
2010-11-18
COLUMBUS, Ohio – Exposure to even dim light at night is enough to cause physical changes in the brains of hamsters that may be associated with depression, a new study shows.
Researchers found that female Siberian hamsters exposed to dim light every night for eight weeks showed significant changes in a part of the brain called the hippocampus.
This is the first time researchers have found that light at night, by itself, may be linked to changes in the hippocampus.
These alterations may be a key reason why the researchers also found that the hamsters exposed to dim ...
2010-11-18
Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit: lowering the risk of severe bacterial infections such as pneumonia and sepsis. A new explanation for these findings has been discovered by researchers at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy & Pharmaceutical Sciences, who describe for the first time how statins activate the bacterial killing properties of white blood cells.
The research is published in the November ...
2010-11-18
Being able to read and understand words like anemia, hormones and seizure means a patient with heart failure may be less likely to be hospitalized, according to a new study from Emory University School of Medicine. Findings will be presented Nov. 17 at the American Heart Association Scientific Sessions conference in Chicago.
The research, led by Emory cardiologist Javed Butler, MD, MPH, professor of medicine, Emory School of Medicine and director of Heart Failure Research at Emory Healthcare, involved the use of a simple test called the Rapid Estimates of Adults Literacy ...
2010-11-18
When cardiac or skeletal muscle is not receiving enough oxygen to meet metabolic demands, a person will experience pain, such as angina, chest pain during a heart attack, or leg pain during a vigorous sprint. This type of pain is called "ischemic" pain and is sensed in the body by receptors on sensory neurons. It has been suggested that lactic acid, which increases during muscle exertion under conditions where oxygen is low, is a potential mediator of ischemic pain via action at acid sensing channel #3 (ASIC3). However, the acid signal it generates is quite subtle and is ...
2010-11-18
SANTA CLARA, Calif. – Embargoed for 2 p.m. EST, November 17, 2010 – Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine ("Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography," Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several ...
2010-11-18
They are often accused of being distracting, but recent research has found that action packed video games like Halo and Call of Duty can enhance visual attention, the ability that allows us to focus on relevant visual information. This growing body of research, reviewed in WIREs Cognitive Science, suggests that action based games could be used to improve military training, educational approaches, and certain visual deficits.
The review, authored by a group led by Dr Daphne Bavelier from the University of Rochester, focused on the impact video games have on visual attention, ...
2010-11-18
WHAT:
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.
To start an infection, anthrax bacteria release a toxin that binds ...
LAST 30 PRESS RELEASES:
[Press-News.org] Wednesday news tips: Nov. 17, 2010
American Heart Association meeting report
